Showing 861 - 880 results of 17,627 for search '"The Progressives"', query time: 0.09s Refine Results
  1. 861

    Libraries in society: comparing international metrics of societal progress to library usage statistics by Margaret Sullivan

    Published 2023-12-01
    “…In the grouping of countries by HDI, literacy, progress, GII and income, the correlation coefficients generally increased for each individual library usage statistic as the indicator improved. …”
    Get full text
    Article
  2. 862

    A 58-Year-Old Female with Progressive Cough and Right Shoulder Pain by Sanket R. Thakore, Faisal A. Khasawneh

    Published 2016-01-01
    “…A 58-year-old stem cell transplant patient was admitted to the hospital with necrotizing pneumonia caused by nocardia. The disease progressed despite of aggrieve antimicrobial therapy. …”
    Get full text
    Article
  3. 863
  4. 864
  5. 865

    Research Progress of Transcranial Direct Current Stimulation Therapy for Cognitive Impairment after Stroke by LIU Yuanchen, ZHANG Lixin

    Published 2024-06-01
    “…This article aims to review the research progress of tDCS and other cognitive rehabilitation methods in PSCI, so as to provide therapeutic experience and reference for the comprehensive rehabilitation of PSCI.…”
    Get full text
    Article
  6. 866
  7. 867
  8. 868
  9. 869

    Deconstruction of “The Pilgrim’s Progress” by John Bunyan in Kurt Vonnegut’s “Slaughterhouse-Five, or The Children’s Crusade” by Nataliya Krynytska

    Published 2024-12-01
    “…He creates an alternative to the pilgrim’s progress in Bunyan’s novel, since the linearity of the development of civilization and Protestant ethics lead to catastrophes like World War II. …”
    Get full text
    Article
  10. 870

    Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway by Qian Wang, Xiumin Xue, Zhichao Chen, Wei Zhang, Yiming Qian, Danni Chen, Lin Lin, Yinfeng Yuan, Weiqiao Zhao, Zhihui Huang, Yongjie Wang

    Published 2025-01-01
    “…Mechanistically, we found that NKT inhibited the progression of GBM cells through activating the ATF4-CHOP-CHAC1 pathway in GBM cells. …”
    Get full text
    Article
  11. 871
  12. 872

    Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1 by Yinghao Guo, Shuangda Miao, Yun Jin, Qi Li, Yihang Wang, Xiaoxiao Zhang, Jiangtao Li

    Published 2025-01-01
    “…Conclusions: TAM promotes CCA progression and chemoresistance through activating OSM-Yap-ID1.…”
    Get full text
    Article
  13. 873
  14. 874

    Research Progress of Fuzheng Jiedu Huayu Method in Reducing Toxicity and Enhancing Efficacy of Immunotherapy by Yufan CHEN, Sicong LI, Yiyuan CUI, Li FENG

    Published 2025-01-01
    “…This article summarizes the research progress of immunotherapy and discusses how TCM reduces the toxicity and enhances the efficacy of immunotherapy, hoping to provide a reference for the integrated treatment of tumors with TCM and immunotherapy.…”
    Get full text
    Article
  15. 875

    Altering the redox status of Chlamydia trachomatis directly impacts its developmental cycle progression by Vandana Singh, Scot P Ouellette

    Published 2025-01-01
    “…Together, these results indicate that redox potential is a critical factor in developmental cycle progression. For the first time, our study provides a mechanism of chlamydial secondary differentiation dependent on redox status.…”
    Get full text
    Article
  16. 876
  17. 877
  18. 878

    Investigating the role of intratumoral Streptococcus mitis in gastric cancer progression: insights into tumor microenvironment by Ping Yang, Gaoli Liang, Yangyue Ni, Xiaojie Chu, Xiaoshan Zhang, Zhongyu Wang, Adeel Khan, Fangfang Jin, Han Shen, Miao Li, Zhipeng Xu

    Published 2025-01-01
    “…Abstract Growing evidence implicates that intratumoral microbiota are closely linked to cancer progression; however, research on the role of these microbiota in the development of gastric cancer remains limited. …”
    Get full text
    Article
  19. 879

    Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm by Charlotte Pawlyn, Fredrik H. Schjesvold, David A. Cairns, L. J. Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos, Jacob Laubach, Katja Weisel, Heinz Ludwig, S. Vincent Rajkumar, Pieter Sonneveld, Graham Jackson, Gareth Morgan, Paul G. Richardson

    Published 2024-08-01
    “…Surrogate endpoints of OS, such as progression-free survival (PFS) and response to treatment, have contributed to approval decisions by the Food and Drug Administration (FDA) and European Medicines Agency as endpoints demonstrating clinical benefit, and the FDA has recently supported the use of minimal residual disease (MRD) as an accelerated approval endpoint in multiple myeloma. …”
    Get full text
    Article
  20. 880